Cargando…

A Pathophysiological Perspective on the SARS-CoV-2 Coagulopathy

Recent evidence is focusing on the presence of a hypercoagulable state with development of both venous and arterial thromboembolic complications in patients infected with SARS-CoV-2. The ongoing activation of coagulation related to the severity of the illness is further characterized by thrombotic m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kusadasi, Nuray, Sikma, Maaike, Huisman, Albert, Westerink, Jan, Maas, Coen, Schutgens, Roger
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430228/ https://www.ncbi.nlm.nih.gov/pubmed/32885147 http://dx.doi.org/10.1097/HS9.0000000000000457

Ejemplares similares

Thromboembolic events and apparent heparin resistance in patients infected with SARS‐CoV‐2
por: Beun, Robert, et al.
Publicado: (2020)

Involvement of ADAMTS13 and von Willebrand factor in thromboembolic events in patients infected with SARS‐CoV‐2
por: Huisman, Albert, et al.
Publicado: (2020)

Coagulopathy and Fibrinolytic Pathophysiology in COVID-19 and SARS-CoV-2 Vaccination
por: Yamada, Shinya, et al.
Publicado: (2022)

Vasculopathy and Coagulopathy Associated with SARS-CoV-2 Infection
por: Labò, Nazzarena, et al.
Publicado: (2020)

Coronavirus-Associated Coagulopathy: Lessons From SARS-CoV1 and MERS-CoV for the Current SARS-CoV2 Pandemic
por: Singh, Shalinder, et al.
Publicado: (2020)

Thrombosis pathways in COVID‐19 vs. influenza‐associated ARDS: A targeted proteomics approach
por: Rademaker, Emma, et al.
Publicado: (2022)

Coagulopathies in novel coronavirus (SARS-CoV-2) pandemic: Emerging evidence for hematologists
por: Al-Subaie, Abeer M.
Publicado: (2021)

Role of SARS-CoV-2 -induced cytokines and growth factors in coagulopathy and thromboembolism
por: Ahmad, Firdos, et al.
Publicado: (2022)

Heparanase as a potential player in SARS-CoV-2 infection and induced coagulopathy
por: Kinaneh, Safa, et al.
Publicado: (2021)

Coagulopathy in SARS-CoV-2 Infected Patients: Implication for the Management of COVID-19
por: Getu, Sisay, et al.
Publicado: (2021)

Recent Advances in Pathophysiology, Drug Development and Future Perspectives of SARS-CoV-2
por: Singh, Desh Deepak, et al.
Publicado: (2020)

Pathophysiology of Coagulopathy in Hematological Malignancies and in COVID-19
por: Levi, Marcel
Publicado: (2021)

SARS‑CoV‑2 and Seizure: An Insight Into the Pathophysiology
por: Ahadiat, Seyed Amir Abbas, et al.
Publicado: (2023)

Coagulopathy and thromboembolic events in patients with SARS-CoV-2 infection: pathogenesis and management strategies
por: Allegra, Alessandro, et al.
Publicado: (2020)

P.121 Acute consumptive coagulopathy in a SARS-CoV-2 positive patient
por: Knight, G., et al.
Publicado: (2021)

Acute Coronary Syndrome in Patients with SARS-CoV-2 Infection: Pathophysiology and Translational Perspectives
por: Cancro, Francesco P., et al.
Publicado: (2022)

COVID-19-associated coagulopathy and antithrombotic agents—lessons after 1 year
por: Leentjens, Jenneke, et al.
Publicado: (2021)

Inflammation Drives Coagulopathies in Sars-Cov-2 Patients
por: Sim, Martha MS, et al.
Publicado: (2020)

An Integrated Approach of the Potential Underlying Molecular Mechanistic Paradigms of SARS-CoV-2-Mediated Coagulopathy
por: Goyal, Anmol, et al.
Publicado: (2021)

Pathophysiology of SARS-CoV-2 associated ischemic stroke
por: Finsterer, Josef, et al.
Publicado: (2022)

Pathophysiology of SARS-CoV-2 in Lung of Diabetic Patients
por: Oliveira, Tales Lyra, et al.
Publicado: (2020)

Heparin and SARS-CoV-2: Multiple Pathophysiological Links
por: Di Micco, Pierpaolo, et al.
Publicado: (2021)

396 Brain pathophysiology in SARS-CoV-2 disease
por: Stanic, Branka Milicic, et al.
Publicado: (2022)

Updated concepts on the pathophysiology and the clinical management of trauma hemorrhage and coagulopathy
por: Maegele, Marc, et al.
Publicado: (2017)

Sepsis-Induced Coagulopathy: An Update on Pathophysiology, Biomarkers, and Current Guidelines
por: Tsantes, Andreas G., et al.
Publicado: (2023)

Interrelationship between COVID-19 and Coagulopathy: Pathophysiological and Clinical Evidence
por: Ragnoli, Beatrice, et al.
Publicado: (2023)

Relevance of Spike/Estrogen Receptor-α interaction for endothelial-based coagulopathy induced by SARS-CoV-2
por: Barbieri, Silvia Stella, et al.
Publicado: (2023)

Pathways of Coagulopathy and Inflammatory Response in SARS-CoV-2 Infection among Type 2 Diabetic Patients
por: Akácsos-Szász, Orsolya-Zsuzsa, et al.
Publicado: (2023)

A case series of coagulopathy in preterm or growth-restricted term neonates born to mothers with antenatal SARS-CoV-2 infection: Neonatal post-COVID-19 coagulopathy?
por: Roy, Shambhawi, et al.
Publicado: (2022)

Gastrointestinal pathophysiology of SARS-CoV2 – a literature review
por: Syed, Anwaruddin, et al.
Publicado: (2020)

Pathophysiology of SARS-CoV-2 infection in patients with intracerebral hemorrhage
por: Dong, Sisi, et al.
Publicado: (2020)

Understanding the epidemiology, pathophysiology, diagnosis and management of SARS-CoV-2
por: Fadaka, Adewale Oluwaseun, et al.
Publicado: (2020)

Pathophysiology of SARS-CoV-2-associated ischemic stroke is variegated
por: Scorza, Fulvio A., et al.
Publicado: (2021)

Understanding the andromeda strain – The role of cytokine release, coagulopathy and antithrombin III in SARS-CoV2 critical illness
por: Mir, Nabiel, et al.
Publicado: (2021)

Pathophysiology of trauma-induced coagulopathy: disseminated intravascular coagulation with the fibrinolytic phenotype
por: Hayakawa, Mineji
Publicado: (2017)

Relative platelet reductions provide better pathophysiologic signatures of coagulopathies in sepsis
por: Kasugai, Daisuke, et al.
Publicado: (2021)

SARS-CoV 2; Possible alternative virus receptors and pathophysiological determinants
por: Pruimboom, Leo
Publicado: (2021)

The pathophysiology of SARS-CoV-2: A suggested model and therapeutic approach
por: Morris, Gerwyn, et al.
Publicado: (2020)

The Prothrombotic State Associated with SARS-CoV-2 Infection: Pathophysiological Aspects
por: Semeraro, Nicola, et al.
Publicado: (2021)

SARS-CoV-2-Induced Pathology—Relevance to COVID-19 Pathophysiology
por: Zinserling, Vsevolod A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ufcdheoo3t2u0omv55ed2r98k0